The Risk of Subarachnoid and Intracerebral Hemorrhages in Blacks as Compared with Whites
NEJM 326:733-736, Broderick,J.P.,et al, 1992
Predictors of Thromboembolism in Atrial Fibrillation:I. Clinical Features of patients at Risk
The Stroke Prevention in A Fib Investigators, Ann Int Med 116:1-51992., , 1992
Cerebral Venous Thrombosis in Behcet's Disease:Clinical Study and Long-Term Follow-Up of 25 Cases
Neurol 42:614-618, Wechsler,B.,et al, 1992
Multifocal Demyelinating Motor Neuropathy:Cranial Nerve Involvement and Immunoglobulin Therapy
Neurol 42:506-509, Kaji,R.,et al, 1992
Secondary Prevention of Stroke
Lancet 339:724-727, Warlow,C., 1992
Role of Ticlopidine for Prevention of Stroke
Stroke 23:912-916, Albers,G.W., 1992
European Stroke Prevention Study:Effectiveness of Antiplatelet Therapy in Diabetics in Secondary Prevent of Stroke
Stroke 23:851-854, Sivenius,J.,et al, 1992
Safety & Efficacy of Intravenous Tissue Plasminogen Activator & Heparin in Acute Middle Cerebral Artery Stroke
Stroke 23:646-652, vonKummer,R.&Hacke,W., 1992
Ticlopidine for Prevention of Stroke
The Medical Letter, 34:65-661992., , 1992
A Critical Appraisal of Ticlopidine, A New Antiplat Agent, Effectiveness & Clin Indic for Prophylaxis
Arch Int Med 152:1376-1380, Haynes,R.B.,et al, 1992
Coma Assoc with Bursts of Abnor Movements & Cognitive Disturb:Acute Encephalopathy of Obscure Origin
J Pediatr 121:845-851, Sebire,G.,et al, 1992
Cerebral Venous Thrombosis
Neurol Clin 10:87-111, Ameri,A.&Bousser,M-G., 1992
Ticlopidine vs Aspirin for Prevention of Recurrent Stroke, Analysis of Pts with Stroke from Ticlopidine Aspirin Study
Stroke 23:1723-1727, Harbison,J.W., 1992
Effects of Low-to-High Doses of Aspirin on Platelet Aggregab & Metabol of Thromboxane A2 & Prostacyclin
Stroke 23:1400-1403, Tohgi,H.,et al, 1992
Low-Dose Aspirin and Stroke"It Ain't Necessarily So"
Stroke 23:1395-1399, Dyken,M.L.,et al, 1992
Prevention of Stroke with Ticlopidine:Who Benefits Most?
Neurol 42:111-115, Grotta,J.C.,et al, 1992
Cardiogenic Embolism to the Brain
Lancet 339:589-594, Hart,R.G., 1992
Fracture of the Occipital Condyle:Case Report
Spine 17:1119-1121, Bozboga,M.,et al, 1992
Primary Lateral Sclerosis, Clin Features, Neuropath & Dx Criteria
Brain 115:495-520, Pringle,C.E.,et al, 1992
Angelman Syndrome: Clinical Profile
J Child Neurol 7:270-280, Zori,R.T.,et al, 1992
Tongue Dyskinesia as an Early Manifestation of Wilson Disease
Brain & Devel 13:451-453, Liao,K.K.,et al, 1991
Antithrombotic Therapy in Cerebrovascular Disease
Ann Int Med 115:885-895, Rothrock,J.F.&Hart,R.G., 1991
Stroke Prevention in Nonvalvular Atrial Fibrillation:A Review of Prospective Randomized Trials
Ann Neurol 30:511-518, Albers,G.W.,et al, 1991
Influence of Low-Intensity Warfarin Treatment of Patients'Perceptions of Quality of Life
Editorial, Arch Int Med 151:1921-1922, 1944-1949991., , 1991
Stroke Prevention in Nonvalvular Atrial Fibrillation
Ann Int Med 115:727-736, Albers,G.W.,et al, 1991
Physicians'Attitudes Toward Anticoag & Antiplat Agents for Stroke Prevent in Elderly Pts with Atrial Fib
Arch Int Med 151:1950-1953, 19221991., Kutner,M.,et al, 1991
Racial Variations in Ischemic Stroke-Related Physical and Functional Impairments
Stroke 22:1497-1501, Horner,R.D.,et al, 1991
Hospitalized Stroke in Blacks and Hispancis in Northern Manhattan
Stroke 22:1491-1496, Sacco,R.L.,et al, 1991
A Comparison of Two Doses of Aspirin (30 mg vs. 283 mg/day) in Pats. After a TIA or Minor Ischemic Stroke
Dutch TIA Trial Study Group, NEJM 325:1261-1266, 1303991., , 1991
Swedish Aspirin Low-Dose Trial (SALT) of 75 mg Aspirin as Secondary Prophylaxis After Cerebrovascular Ischaemic Events
The SALT Coll Group, Lancet 338:1345-13491991., , 1991
Dissection of the Extracranial Vertebral Artery:Report of Four Cases and Review of the Literature
JNNP 54:863-869, Hinse,P.,et al, 1991
Ticlopidine
Editorial, Lancet 337:459-4601991., , 1991
Racial Differences in Cerebrovascular Disease Hospitalizations
Stroke 22:299-304, Klatsky,A.L.,et al, 1991
One-Year Outcome after Cerebral Infarction in Whites, Blacks, and Hispanics
Stroke 22:305-311, Sacco,R.L., 1991
Thrombotic Thrombocytopenic Purpura Related to Ticlopidine
Lancet 337:774-776, Page,Y.,et al, 1991
Heparin Treatment in Sinus Venous Thrombosis
Lancet 338:597-600, Einhaupl,K.M.,et al, 1991
Aspirin in the Prevention of Thrombosis
Medicine 70:161-178, Lekstrom,J.A.&Bell,W.R., 1991
The European Stroke Prevention Study:Results According to Sex
Neurol 41:1189-1192, Sivenius,J.,et al, 1991
Atrial Fibrillation as an Independent Risk Factor for Stroke:The Framingham Study
Stroke 22:983-988, Wolf,P.A.,et al, 1991
Antiphospholipid Antibodies in Cerebral Ischemia
Stroke 22:750-753, Montalban,J.,et al, 1991
Clinical Characteristics of Transient Ischemic Attacks in Black Patients
Neurol 41:1410-1414, Weisberg,L.A., 1991
Cardiovascular Diseases and Stroke in African-Americans and Other Racial Minorities in the US
Stroke 22:551-568, , 1991
Estimated Prevalence of Dementia Among Elderly Black and White Community Residents
Arch Neurol 48:594-598, Heyman,A.,et al, 1991
Abnormal Eye Movements Encountered Following Severe Envenomations by Centruroides Sculpturatus
Neurol 41:604-605, Clark,R.F.,et al, 1991
Atrial Fibrillation as a Risk Factor for Deep Venous Thrombosis and Pulmonary Emboli in Stroke Patients
Stroke 22:760-762, Noel,P.,et al, 1991
Clinical and Electrodignostic Features of X-Linked Recessive Bulbospinal Neuronopathy
Neurol 41:823-828, Olney,R.K.,et al, 1991
Stroke Prevention in Women:role of Aspirin Versus Ticlopidine
Am J Med 91:288-292, Hershey,L.A., 1991
Ultrasound Findings in Spontaneous Carotid Artery Dissection, The Value of Duplex Sonography
Arch Neurol 48:1057-1063, Sturzenegger,M., 1991
Diagnosis and Treatment of Ischemic Stroke
JAMA 266:2413-2418, Caplan,L.R., 1991
Babinski-Nageotte Syndrome on Magnetic Resonance Imaging
Stroke 22:272-275, Nakane,H.,et al, 1991